Dermatology NewsGuide to the guidelines: Biologics for psoriasisOctober 4, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsObesity, moderate drinking linked to psoriatic arthritisSeptember 18, 2019Psoriatic ArthritisPsoriasis
Dermatology NewsLong-term advantages may not endure after early tight control in psoriatic arthritisSeptember 11, 2019Psoriatic Arthritis
Dermatology NewsPsoriasis patients on biologics show improved heart healthAugust 7, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsFDA finds increased blood clot, death risk associated with XeljanzJuly 26, 2019Psoriatic Arthritis
Dermatology NewsHadlima approved as fourth adalimumab biosimilar in U.S.July 23, 2019Psoriatic ArthritisPsoriasisPediatrics
Dermatology NewsSecukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trialJuly 16, 2019Psoriatic Arthritis
Dermatology NewsTildrakizumab shows positive effects in active psoriatic arthritisJuly 8, 2019Psoriatic Arthritis
Dermatology NewsIxekizumab boosts quality of life in genital psoriasisJuly 5, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsUnacceptable pain despite inflammation control commonly occurs in PsA patientsJuly 2, 2019Psoriatic Arthritis
Dermatology NewsInfections linked with transition to psoriatic arthritisJune 28, 2019Psoriatic Arthritis
Dermatology NewsSystemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response ratesJune 27, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsObesity might be targetable driver of psoriatic arthritis progressionJune 26, 2019Psoriatic Arthritis
Dermatology NewsIxekizumab surpasses adalimumab in PsA head-to-head studyJune 16, 2019Psoriatic Arthritis
